BioCentury
ARTICLE | Company News

Vertex, Enterome Bioscience deal

May 2, 2016 7:00 AM UTC

Vertex granted Enterome exclusive, worldwide rights to small molecule antagonists of bacterial fimbrial adhesin (fimH), including lead compound EB 8018, to treat inflammatory bowel disease (IBD). En...